Current and Investigational Drug Strategies for Glioblastoma

Ajaz, M, Jefferies, S, Brazil, L, Watts, C and Chalmers, A (2014) Current and Investigational Drug Strategies for Glioblastoma CLINICAL ONCOLOGY, 26 (7). pp. 419-430.

Text (licence) SRI_deposit_agreement.pdf Restricted to Repository staff only Available under License : See the attached licence file. Download (33kB)

Item Type:	Article
Divisions :	Surrey research (other units)
Authors :	Ajaz, M, Jefferies, S, Brazil, L, Watts, C and Chalmers, A
Date :	1 July 2014
DOI :	10.1016/j.clon.2014.03.012
Uncontrolled Keywords :	Science & Technology, Life Sciences & Biomedicine, Oncology, ONCOLOGY, Chemotherapy, clinical trials, glioblastoma multiforme, new agents, RECURRENT MALIGNANT GLIOMA, HIGH-GRADE GLIOMA, PHASE-II TRIAL, NEWLY-DIAGNOSED GLIOBLASTOMA, DOSE-INTENSE TEMOZOLOMIDE, BRAIN-TUMOR CONSORTIUM, BEVACIZUMAB PLUS IRINOTECAN, INTEGRATED GENOMIC ANALYSIS, TYROSINE KINASE INHIBITORS, ENDOTHELIAL GROWTH-FACTOR
Related URLs :	Author
Depositing User :	Symplectic Elements
Date Deposited :	28 Mar 2017 15:32
Last Modified :	24 Jan 2020 12:57
URI:	http://epubs.surrey.ac.uk/id/eprint/811419

Actions (login required)

View Item

Downloads